IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS

92 reported adverse events

Drug classes: Penem Antibacterial [EPC] Renal Dehydropeptidase Inhibitor [EPC] beta Lactamase Inhibitor [EPC]

These side effects are most commonly reported by patients taking IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS:

# Side effect Count
0 OFF LABEL USE 18
1 DEATH 14
2 PRODUCT USE IN UNAPPROVED INDICATION 9
3 PATHOGEN RESISTANCE 8
4 DRUG INEFFECTIVE 6
5 CARDIO-RESPIRATORY ARREST 5
6 GENERALISED TONIC-CLONIC SEIZURE 5
7 OVERDOSE 5
8 EPILEPSY 4
9 RENAL IMPAIRMENT 4
See all common reactions for IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS

IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EPIDURAL CATHETER PLACEMENT 2 0.1538
1 SUBDURAL ABSCESS 3 0.0652
2 MICROBIOLOGY TEST ABNORMAL 1 0.0169
3 EXTUBATION 1 0.0123
4 HAEMOFILTRATION 1 0.0053
5 EXTRADURAL ABSCESS 3 0.0038
6 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1 0.0032
7 KLEBSIELLA BACTERAEMIA 3 0.0032
8 STENOTROPHOMONAS INFECTION 3 0.0022
9 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
See all enriched reactions for IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS